HK Stock Market Move | REPT BATTERO(00666) rose by over 7%, energy storage battery cells are in short supply, the company turned losses into profits last year.
Rui Pulu Jun (00666) rose more than 7% during trading, up 5.96% as of the deadline, at HK$16.19, with a turnover of HK$55.3019 million.
REPT BATTERO (00666) rose more than 7% during trading, and as of the time of publication, it had risen by 5.96% to 16.19 Hong Kong dollars, with a trading volume of 55.3019 million Hong Kong dollars.
In terms of news, according to 21st Century Business Herald, reporters have recently learned from multiple sources that the domestic energy storage battery cell production capacity has entered a state of supply shortage, with leading companies already having energy storage battery cell orders scheduled until the end of the first quarter of 2027. The spot price of battery cells has rebounded significantly from the low point in 2025, and the industry's bargaining power has reversed. According to Battery China, the production of energy storage battery cells in April hit a record high, and leading manufacturers have started to "pick orders."
It is worth noting that the 2025 performance of REPT BATTERO showed that the group generated revenue of 24.334 billion yuan, a year-on-year increase of 36.74%; gross profit of 2.721 billion yuan, a year-on-year increase of 269.24%; and a net profit attributable to the owners of the parent company of 623 million yuan, turning a loss into a profit year-on-year. According to statistics from the Shanghai Nonferrous Network, in 2025, the group ranked among the top five in global energy storage battery cell shipments, and its shipment of household energy storage battery cells ranked first globally.
Related Articles

BAO PHARMA-B(02659): Injectable hyaluronidase approved by the National Medical Products Administration for listing.

A-share midday review | Epic short squeeze situation! A-shares boiling, ChiNext index up 4.81% in half a day, how to layout TACO trading?

HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 14% in the morning trading session. The price of silicon carbide substrates rebounded and the industry is expected to see a turning point in recovery.
BAO PHARMA-B(02659): Injectable hyaluronidase approved by the National Medical Products Administration for listing.

A-share midday review | Epic short squeeze situation! A-shares boiling, ChiNext index up 4.81% in half a day, how to layout TACO trading?

HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 14% in the morning trading session. The price of silicon carbide substrates rebounded and the industry is expected to see a turning point in recovery.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


